⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

VITRUVIAS THERAPEUTICS INC: Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, D

DrugsSource: FDA (drug) · Date: 2026-09-23

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
VITRUVIAS THERAPEUTICS INC
Product
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Reason / hazard
Superpotent Drug
Classification
Class I
Status
Ongoing
Distribution / sold at
US Nationwide.
Recall initiated
2026-08-21
Code info
Lot # 504950, Exp Date: 09/30/2026.
Product quantity
1955 bottles
Voluntary mandated
Voluntary: Firm initiated
City
Auburn
State
AL
Country
United States
Event id
99709
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.